<SEC-DOCUMENT>0001214659-25-010280.txt : 20250710
<SEC-HEADER>0001214659-25-010280.hdr.sgml : 20250710
<ACCEPTANCE-DATETIME>20250710184538
ACCESSION NUMBER:		0001214659-25-010280
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250710
DATE AS OF CHANGE:		20250710

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RENOVARO INC.
		CENTRAL INDEX KEY:			0001527728
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				452259340
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-86428
		FILM NUMBER:		251117253

	BUSINESS ADDRESS:	
		STREET 1:		CENTURY CITY MEDICAL PLAZA
		STREET 2:		2080 CENTURY CITY EAST
		CITY:			SUITE 906 LOS ANGELES
		STATE:			CA
		ZIP:			90067
		BUSINESS PHONE:		45 39179840

	MAIL ADDRESS:	
		STREET 1:		CENTURY CITY MEDICAL PLAZA
		STREET 2:		2080 CENTURY CITY EAST
		CITY:			SUITE 906 LOS ANGELES
		STATE:			CA
		ZIP:			90067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RENOVARO BIOSCIENCES INC.
		DATE OF NAME CHANGE:	20230807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Enochian Biosciences Inc.
		DATE OF NAME CHANGE:	20230804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Renovaro Biosciences Inc.
		DATE OF NAME CHANGE:	20230802

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			William Anderson Wittekind
		CENTRAL INDEX KEY:			0001753085
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		8581 SANTA MONICA BLVD
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90069
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0001214659-23-007572</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: William Anderson Wittekind -->
          <cik>0001753085</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>21</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.0001 per share</securitiesClassTitle>
      <dateOfEvent>07/09/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001527728</issuerCIK>
        <issuerCUSIP>29350E104</issuerCUSIP>
        <issuerName>Renovaro Inc.</issuerName>
        <address>
          <com:street1>CENTURY CITY MEDICAL PLAZA</com:street1>
          <com:street2>2080 CENTURY CITY EAST</com:street2>
          <com:city>SUITE 906 LOS ANGELES</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>90067</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>William Anderson Wittekind</personName>
          <personPhoneNum>(424) 235-1810</personPhoneNum>
          <personAddress>
            <com:street1>8581 Santa Monica Blvd.</com:street1>
            <com:street2>#317</com:street2>
            <com:city>West Hollywood</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>90069</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Patrick T. McCloskey</personName>
          <personPhoneNum>646.970.0611</personPhoneNum>
          <personAddress>
            <com:street1>McCloskey Law PLLC</com:street1>
            <com:street2>260 Madison Avenue, 15th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10016</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001753085</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>William Anderson Wittekind</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>5606644.00</soleVotingPower>
        <sharedVotingPower>12526552.00</sharedVotingPower>
        <soleDispositivePower>5606644.00</soleDispositivePower>
        <sharedDispositivePower>12526552.00</sharedDispositivePower>
        <aggregateAmountOwned>18133196.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>8.0</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>The number of shares disclosed in Rows 7 and 9 consist of (i) 3,265,757 shares owned by William Anderson Wittekind ("Wittekind"); (ii) 840,319 shares owned by Weird Science LLC ("Weird Science"); (iii) 633,921 shares owned by the William Anderson Wittekind 2020 Annuity Trust, a grantor retained annuity trust  of which Wittekind is the sole trustee (the "Wittekind 2020 Annuity Trust"); (iv) 450,568 shares owned by the Dybul 2020 Angel Annuity Trust, a grantor retained trust of which Wittekind is the sole trustee (the "Dybul 2020 Annuity Trust"); (v) 50,000 shares owned by the Ty Mabry 2021 Annuity Trust, a grantor retained annuity trust of which Wittekind is sole trustee (the "Mabry 2021 Annuity Trust"); and (vi) 366,079 shares owned by the William Anderson Wittekind 2021 Annuity Trust, a grantor retained annuity trust of which Wittekind is the sole trustee (the "Wittekind 2021 Annuity Trust" and, together with the Wittekind 2020 Annuity Trust, the Dybul 2020 Annuity Trust and the Mabry 2021 Annuity Trust, the "Trusts"). In his capacity as the sole manager of Weird Science, Wittekind has sole voting and sole dispositive power over the shares owned by Weird Science. In his capacity as the sole trustee of the Trusts, Wittekind has sole voting power and sole dispositive power over the shares owned by the Trusts.
(2) The number of shares disclosed in Rows 8 and 12 consists of (i) 88,121 shares owned by Wittekind and Serhat Gumrukcu, Wittekind's spouse ("Gumrukcu"), as joint tenants with a right of survivorship ("JTWROS") and (ii) 12,438,431 shares owned by Gumrukcu, of which Wittekind shares voting and dispositive power through a power of attorney dated June 24, 2022. Pursuant to an order of the United States District Court for the District of Vermont dated October 27, 2023, the 12,438,431 shares owned by Gumrukcu are subject to a writ of attachment to secure the plaintiffs' claim in The Estate of Gregory Davis et al. v. Serhat Daniel Gumrukcu (Civil Case No. 5:22-cv-123).
(3) The percentage ownership disclosed in Row 13 is based upon (i) 172,7118,569 shares outstanding as of May 13, 2025, as disclosed in the Issuer's Form 10-Q filed with the Commission on May 15, 2025 plus (ii) 53,600,000 shares to be issued on or before July 11, 2025 upon conversion of convertible notes as reported in the Issuer's Form 8-K filed with the Commission on July 9, 2025.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.0001 per share</securityTitle>
        <issuerName>Renovaro Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>CENTURY CITY MEDICAL PLAZA</com:street1>
          <com:street2>2080 CENTURY CITY EAST</com:street2>
          <com:city>SUITE 906 LOS ANGELES</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>90067</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This Amendment No. 21 amends the Schedule 13D filed by Weird Science LLC, a California limited liability company ("Weird Science") and William Anderson Wittekind, a member and manager of Weird Science ("Wittekind") with respect to the shares of common stock, par value $0.0001 per share ("Common Stock") of Renovaro Inc. (the "Issuer") received by Weird Science pursuant to that certain Agreement and Plan of Merger dated January 12, 2018 (the "Merger Agreement") by and among the Issuer (then known as DanDrit BioTech USA, Inc.), DanDrit Acquisition Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Issuer ("Merger Sub"), Renovaro Biopharma, Inc., a Delaware corporation then known as Enochian Biopharma Inc. ("Target"), and Weird Science, in its capacity as the majority stockholder of the Target, as amended by Amendment Nos. 1 through 20 thereto. Wittekind is the sole reporting person under this Amendment No. 21 to Schedule 13D (the "Reporting Person").

Capitalized terms used but not defined in this Amendment No. 21 have the meanings given to such terms in the initial Schedule 13D, as amended by Amendment Nos. 1 through 20 thereto.

On Wednesday, July 9, 2025 the Issuer filed a Form 8-K with the Commission reporting that it would issue 53,600,000 shares of Common Stock on or before July 11, 2025 upon the conversion of convertible notes. Based upon the Issuer's Form 10-Q filed with the Commission on May 15, 2025, there were 172,118,569 shares of Common Stock issued and outstanding as of May 13, 2025. Effective as of the issuance of the 53,600,000 shares upon conversion of the convertible notes, the Reporting Person's beneficial ownership will decrease from the 10.4% reported in Amendment 20 to 8.0%.</commentText>
      </item1>
      <item2>
        <filingPersonName>William Anderson Wittekind</filingPersonName>
        <principalBusinessAddress>8581 Santa Monica Blvd., #317, West Hollywood, CA, 90069</principalBusinessAddress>
      </item2>
      <item4>
        <transactionPurpose>Not Applicable.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>The information in Items 7-11 and Item 13 of the Cover Page of this Amendment No. 21, including the accompany notes, is hereby incorporated by reference into this Item 5(a).</percentageOfClassSecurities>
        <numberOfShares>The information in Items 7-11 and Item 13 of the Cover Page of this Amendment No. 21, including the accompany notes, is hereby incorporated by reference into this Item 5(b).</numberOfShares>
        <transactionDesc>Not Applicable</transactionDesc>
        <listOfShareholders>Not applicable</listOfShareholders>
        <date5PercentOwnership>Not applicable</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Not Applicable.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Not applicable.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>William Anderson Wittekind</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ William Anderson Wittekind</signature>
          <title>William Anderson Wittekind</title>
          <date>07/10/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
